The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma (Q39062237)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 November 2013

Language	Label	Description	Also known as
English	The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma	scientific article published on 29 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Elke Pogge von Strandmann

17

object named as

Elke Pogge von Strandmann

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sampurna Chatterjee

object named as

Sampurna Chatterjee

10

0 references

16

object named as

Michael Hallek

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Achim Rothe

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Ron D Jachimowicz

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sven Borchmann

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Marie Madlener

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jörg Keßler

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Katrin S Reiners

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Maike Sauer

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Hinrich P Hansen

8

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Roland T Ullrich

9

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Peter Borchmann

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Paul Yazaki

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Thomas C Koslowsky

13

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Andreas Engert

14

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Lukas C Heukamp

15

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

29 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

134

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

2829-2840

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Antibody-based therapy for solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Up on the tightrope: natural killer cell activation and inhibition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Prospects for the use of NK cells in immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

UL16 binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Soluble NKG2D ligands: prevalence, release, and functional impact.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Effect of NKG2D ligand expression on host immune responses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

NK cells interactions with dendritic cells shape innate and adaptive immunity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Natural killer cell-directed therapies: moving from unexpected results to successful strategies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Emerging natural killer cell immunotherapies: Large-scale ex vivo production of highly potent anticancer effectors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Use of allogeneic NK cells for cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Densely granulated murine NK cells eradicate large solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Tumor-associated MICA is shed by ADAM proteases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.28609

21 January 2018

Identifiers

10.1002/IJC.28609

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39062237&oldid=1806154232"